Evidence map›Paper›PMID 26201986›Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2016

Impact of diabetes on healthcare costs in a population-based cohort: a cost analysis.

L C Rosella, M Lebenbaum, T Fitzpatrick, D O'Reilly, J Wang, G L Booth, T A Stukel, W P Wodchis

Open access · hybridAbstract read
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
36.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Cost-effectiveness of implementing the National Health Service England Diabetes Prevention Programme in Canada: a modelling study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

L C RosellaDalla Lana School of Public Health, University of Toronto, Toronto, Canada.
M LebenbaumPublic Health Ontario, Toronto, Canada.
T FitzpatrickPublic Health Ontario, Toronto, Canada.
D O'ReillyDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada.
J WangPublic Health Ontario, Toronto, Canada.
G L BoothInstitute for Clinical Evaluative Sciences, Toronto, Canada.
T A StukelInstitute for Clinical Evaluative Sciences, Toronto, Canada.
W P WodchisInstitute for Clinical Evaluative Sciences, Toronto, Canada.
Institute for Clinical Evaluative Sciences · CAPublic Health Ontario · CAPrograms for Assessment of Technology in Health Research Institute · CASt. Michael's Hospital · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

aimsTo estimate the healthcare costs attributable to diabetes in Ontario, Canada using a propensity-matched control design and health administrative data from the perspective of a single-payer healthcare system.

methodsIncident diabetes cases among adults in Ontario were identified from the Ontario Diabetes Database between 2004 and 2012 and matched 1:3 to control subjects without diabetes identified in health administrative databases on the basis of sociodemographics and propensity score. Using a comprehensive source of administrative databases, direct per-person costs (Canadian dollars 2012) were calculated. A cost analysis was performed to calculate the attributable costs of diabetes; i.e. the difference of costs between patients with diabetes and control subjects without diabetes.

resultsThe study sample included 699 042 incident diabetes cases. The costs attributable to diabetes were greatest in the year after diagnosis [C$3,785 (95% CI 3708, 3862) per person for women and C$3,826 (95% CI 3751, 3901) for men], increasing substantially for older age groups and patients who died during follow-up. After accounting for baseline comorbidities, attributable costs were primarily incurred through inpatient acute hospitalizations, physician visits and prescription medications and assistive devices.

conclusionsThe excess healthcare costs attributable to diabetes are substantial and pose a significant clinical and public health challenge. This burden is an important consideration for decision-makers, particularly given increasing concern over the sustainability of the healthcare system, aging population structure and increasing prevalence of diabetic risk factors, such as obesity.

Indexed as

AdultAgedAged, 80 and overCanadaCase-Control StudiesCohort StudiesDiabetes Mellitus, Type 2FemaleHealth Care CostsHumansMaleMiddle AgedOntarioPrevalenceYoung Adult

Identifiers

PMID26201986
PMCPMC5014203
OpenAlexW2159205453

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.